I am of the view that Acadia put itself up for sale today with its flashy business and pipeline update with no less than seven bullet points one of which being expected 2025 annual revenue in excess of $1 billion. The company has been around for 30 years and provides a potential acquirer with 30 years of tax losses to utilize, lots of cash on the balance sheet, and all that revenue. Would not be surprised if Acadia becomes a big pharma subsidiary this year. Pfizer picked up Baker Brothers lady big holding SGEN. The business and pipeline update today was the equivalent of Acadia dropping a big juicy worm as bait into a stocked pond. As for Neuren, Jon’s silence is deafening. I hope it’s forced silence due to a potential acquisition, which would also explain Little T joining the witness protection program, and the dramatic halt in the share buyback in the second half of December.
- Forums
- ASX - By Stock
- NEU
- Share Price
NEU
neuren pharmaceuticals limited
Add to My Watchlist
3.17%
!
$17.55

Share Price, page-13864
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.55 |
Change
0.540(3.17%) |
Mkt cap ! $2.211B |
Open | High | Low | Value | Volume |
$17.48 | $18.44 | $17.40 | $16.43M | 922.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2624 | $17.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.70 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2624 | 17.530 |
3 | 4257 | 17.500 |
1 | 1500 | 17.410 |
1 | 57 | 17.380 |
3 | 12000 | 17.350 |
Price($) | Vol. | No. |
---|---|---|
17.700 | 1000 | 1 |
17.750 | 50 | 1 |
17.780 | 200 | 1 |
17.810 | 50 | 1 |
17.910 | 2000 | 1 |
Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |